Skip to main content

Advertisement

Table 4 Population size, deaths, and unadjusted and adjusted mortality rate per 1000 person-years (PY), overall and by select characteristics

From: Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada

  Populationa Deaths Person Years (PY) Unadjusted mortality rate per 1000PY (SE) Adjustedb mortality rate per 1000PY (SE)
Overall 9997 830 49588.88 16.74 (0.58) 23.59 (0.69)
Sex      
Female 1831 184 9303.73 19.78 (1.46) 27.09 (1.71)
Male 8166 646 40285.14 16.04 (0.63) 22.79 (0.75)
History of IDU      
Yes 2141 377 11082.71 34.02 (1.75) 45.21 (2.02)
No 5702 257 28875.05 8.90 (0.56) 12.81 (0.67)
Aboriginal ancestry      
Yes 467 123 2398.97 51.27 (4.62) 58.36 (4.93)
No 4275 255 24627.65 10.35 (0.65) 14.74 (0.77)
Baseline CD4 (cells/μL)      
<350 7689 740 41016.06 18.04 (0.66) 25.55 (0.79)
≥350 2308 90 8572.82 10.50 (1.12) 14.23 (1.29)
Year of ART initiation      
2000–2003 2381 399 20389.75 19.57 (0.98) 31.29 (1.24)
2004–2007 3058 287 17928.23 16.01 (0.95) 21.03 (1.08)
2008–2012 4558 144 11270.90 12.78 (1.07) 13.75 (1.11)
  1. SE standard error, IDU injection drug use, ART antiretroviral therapy
  2. aAnalyses restricted to those with non-missing data
  3. bIncluding assumed 30 % mortality in participants lost to follow-up